filmov
tv
Timothy Hughes - Chronic Myeloid Leukaemia (CML) News
Показать описание
Timothy Hughes at The European Hematology Association (EHA) Conference in Stockholm talking about Chronic Myeloid Leukaemia (CML) News
Leukaemia Care
Рекомендации по теме
0:02:10
Timothy Hughes - Chronic Myeloid Leukaemia (CML) News
0:01:27
Timothy Hughes - Chronic Myeloid Leukaemia (CML) News
0:09:48
Chronic Myeloid Leukaemia (CML) with Professor Tim Hughes
0:09:48
Talking chronic myeloid leukaemia (CML) with Professor Tim Hughes
0:02:10
The importance of achieving early molecular response in CML
0:08:25
Interview Timothy Hughes and Jorge Cortes
0:04:22
Professor Timothy P Hughes summarizes the most important CML news presented at ASH19
0:01:09
Timothy Hughes - Treatment Free Remission (TFR)
0:00:55
Final analysis from a Phase I trial of asciminib in T315I-mutated CML-CP
0:00:51
Physicians must perform molecular monitoing regularly for successful outcomes in CML
0:00:38
ENESTnd 5-year follow-up in patients with chronic myeloid leukemia in chronic phase from EHA 2014
0:00:56
Update on the ASCEND-CML study investigating frontline asciminib for patients with CML
0:01:33
ENESTop: deep molecular response in CML can be translated into treatment-free remission
0:01:26
The efficacy of nilotinib treatment approaches in frontline CML
0:02:36
Update on ENESTop: TFR in CML after discontinuing nilotinib
2:34:19
7th PSH Webinar | Chronic Myeloid Leukemia (CML) | 16 December, 2020
0:01:08
Managing drug resistance in CP-CML with ponatinib and asciminib
0:02:20
Clinical trial updates in CML
0:01:13
The ALLG CML13 ASCEND-CML study: high major molecular responses with asciminib treatment for CP-CML
0:05:01
Welcome message: 22nd John Goldman E-Conference on Chronic Myeloid Leukemia: Biology and Therapy
0:03:26
Asciminib: overcoming TKI resistance and reducing toxicity in CML
0:03:18
Predictors for TFR in CML: response duration, secondary treatment & frontline TKI choice
0:23:40
CML - Understanding your diagnosis
0:22:37
SOHO 2015: Discussion on Current Issues in Chronic Myeloid Leukemia (CML)
join shbcf.ru
0:02:10
0:01:27
0:09:48
0:09:48
0:02:10
0:08:25
0:04:22
0:01:09
0:00:55
0:00:51
0:00:38
0:00:56
0:01:33
0:01:26
0:02:36
2:34:19
0:01:08
0:02:20
0:01:13
0:05:01
0:03:26
0:03:18
0:23:40
0:22:37